Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice.
about
A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.Butyrate Reduces HFD-Induced Adipocyte Hypertrophy and Metabolic Risk Factors in Obese LDLr-/-.Leiden Mice.The Transcriptome of Estrogen-Independent Mammary Growth in Female Mice Reveals That Not All Mammary Glands Are Created Equally.Key Inflammatory Processes in Human NASH Are Reflected in Ldlr-/-.Leiden Mice: A Translational Gene Profiling Study.Ghrelin Stimulates Endothelial Cells Angiogenesis through Extracellular Regulated Protein Kinases (ERK) Signaling Pathway
P2860
Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reduction of obesity-associate ...... isease in LDLr-deficient mice.
@en
Reduction of obesity-associate ...... isease in LDLr-deficient mice.
@nl
type
label
Reduction of obesity-associate ...... isease in LDLr-deficient mice.
@en
Reduction of obesity-associate ...... isease in LDLr-deficient mice.
@nl
prefLabel
Reduction of obesity-associate ...... isease in LDLr-deficient mice.
@en
Reduction of obesity-associate ...... isease in LDLr-deficient mice.
@nl
P2093
P2860
P356
P1433
P1476
Reduction of obesity-associate ...... disease in LDLr-deficient mice
@en
P2093
J Hajo van Bockel
Lars Verschuren
Peter Y Wielinga
Robert Kleemann
Teake Kooistra
P2860
P2888
P356
10.1038/SREP31542
P407
P577
2016-08-22T00:00:00Z